Stability of plasmid and viral banks supporting the cGMP manufacture of Q-Griffithsin from a TMV-based viral vector.


Journal

Journal of biotechnology
ISSN: 1873-4863
Titre abrégé: J Biotechnol
Pays: Netherlands
ID NLM: 8411927

Informations de publication

Date de publication:
20 Aug 2020
Historique:
received: 21 02 2020
revised: 02 06 2020
accepted: 12 06 2020
pubmed: 20 6 2020
medline: 9 2 2021
entrez: 20 6 2020
Statut: ppublish

Résumé

The "whole genome" TMV-based expression system, Geneware®, was used in the cGMP production of the plant-made pharmaceutical Q-Griffithsin and demonstrates stable expression for up to a two-year period. Virion and plasmid banks which contained viral cDNA and a Q-Griffithsin sequence were able to produce >200 g of Q-Griffithsin. Data assessing the quality and stability of the product banks were measured through functional assessments of visual symptomology and product expression.

Identifiants

pubmed: 32553533
pii: S0168-1656(20)30156-5
doi: 10.1016/j.jbiotec.2020.06.009
pmc: PMC7397727
mid: NIHMS1607511
pii:
doi:

Substances chimiques

Anti-Infective Agents 0
Lectins 0
Plant Lectins 0
Recombinant Proteins 0
q-griffithsin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

74-76

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI113182
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest KEP, JLF, and KTH are inventors on patents and patent applications that claim Q-GRFT composition and utility. In addition, KEP, JLF, and KTH are founders and equity holders in GROW Biomedicine LLC, which is commercializing Q-GRFT. EH, JMC, JWS declare no conflicts of interest.

Références

Virology. 1999 Mar 15;255(2):312-23
pubmed: 10069957
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6099-104
pubmed: 19332801
Viruses. 2016 Oct 24;8(10):
pubmed: 27783038
Methods Mol Biol. 2016;1385:129-37
pubmed: 26614286
Front Bioeng Biotechnol. 2018 Jul 24;6:102
pubmed: 30087892
Virology. 2007 Sep 15;366(1):98-106
pubmed: 17493658
Plant Biotechnol J. 2015 Oct;13(8):1160-8
pubmed: 26176205
Plant Physiol. 2010 Aug;153(4):1859-70
pubmed: 20498336
Plant Biotechnol J. 2010 Jun;8(5):638-54
pubmed: 20514694

Auteurs

Julia M Corman (JM)

Center for Predictive Medicine, University of Louisville School of Medicine, Louisville KY, USA.

Krystal T Hamorsky (KT)

James Graham Brown Cancer Center, University of Louisville School of Medicine,Louisville KY, USA; Center for Predictive Medicine, University of Louisville School of Medicine, Louisville KY, USA; Department of Medicine, University of Louisville School of Medicine, Louisville KY, USA.

John W Shepherd (JW)

Kentucky Bioprocessing Inc., Owensboro, KY, USA.

Ernie Hiatt (E)

R.J. Reynolds Tobacco Co., Winston-Salem, NC, USA.

Joshua L Fuqua (JL)

James Graham Brown Cancer Center, University of Louisville School of Medicine,Louisville KY, USA; Center for Predictive Medicine, University of Louisville School of Medicine, Louisville KY, USA; Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville KY, USA. Electronic address: j.fuqua@louisville.edu.

Kenneth E Palmer (KE)

James Graham Brown Cancer Center, University of Louisville School of Medicine,Louisville KY, USA; Center for Predictive Medicine, University of Louisville School of Medicine, Louisville KY, USA; Department of Pharmacology and Toxicology, University of Louisville School of Medicine, Louisville KY, USA.

Articles similaires

Genome, Bacterial Virulence Phylogeny Genomics Plant Diseases
Saccharomyces cerevisiae Aldehydes Biotransformation Flavoring Agents Lipoxygenase
Arabidopsis Amorphophallus Plants, Genetically Modified Phylogeny Droughts
Humans COVID-19 United Kingdom Surveys and Questionnaires Biological Specimen Banks

Classifications MeSH